|
1
|
Ehtesham H, Safdari R, Mansourian A,
Tahmasebian S, Mohammadzadeh N, Ghazisaeedi M and Bashiri A:
Clinical decision support system, a potential solution for
diagnostic accuracy improvement in oral squamous cell carcinoma: A
systematic review. J Oral Health Oral Epidemiol. 6:187–195.
2017.
|
|
2
|
Marur S and Forastiere AA: Head and neck
squamous cell carcinoma: Update on epidemiology, diagnosis, and
treatment. Mayo Clin Proc. 91:386–396. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Velmurugan BK, Yeh KT, Lee CH, Lin SH,
Chin MC, Chiang SL, Wang ZH, Hua CH, Tsai MH, Chang JG and Ko YC:
Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association
with lymph node metastasis predicts poor survival in oral squamous
cell carcinoma patients. Oncotarget. 7:10879–10890. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chi HC, Tsai CY, Tsai MM and Lin KH:
Impact of DNA and RNA methylation on radiobiology and cancer
progression. Int J Mol Sci. 19:E5552018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khor GH, Froemming GR, Zain RB, Abraham
MT, Omar E, Tan SK, Tan AC, Vincent-Chong VK and Thong KL: DNA
methylation profiling revealed promoter hypermethylation-induced
silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell
carcinoma. Int J Med Sci. 10:1727–1739. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Basu B, Chakraborty J, Chandra A, Katarkar
A, Baldevbhai JR, Chowdhury Dhar D, Ray JG, Chaudhuri K and
Chatterjee R: Genome-wide DNA methylation profile identified a
unique set of differentially methylated immune genes in oral
squamous cell carcinoma patients in India. Clin Epigenetics.
9:132017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Clausen MJ, Melchers LJ, Mastik MF,
Slagter-Menkema L, Groen HJ, van der Laan BF, van Criekinge W, de
Meyer T, Denil S, Wisman GB, et al: Identification and validation
of WISP1 as an epigenetic regulator of metastasis in oral squamous
cell carcinoma. Genes Chromosomes Cancer. 55:45–59. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shen L, Kondo Y, Guo Y, Zhang J, Zhang L,
Ahmed S, Shu J, Chen X, Waterland RA and Issa JP: Genome-wide
profiling of DNA methylation reveals a class of normally methylated
CpG island promoters. PLoS Genet. 3:2023–2036. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garcia MP and Garcia-Garcia A: Epigenome
and DNA methylation in oral squamous cell carcinoma. Methods Mol
Biol. 863:207–219. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jithesh PV, Risk JM, Schache AG, Dhanda J,
Lane B, Liloglou T and Shaw RJ: The epigenetic landscape of oral
squamous cell carcinoma. Br J Cancer. 108:370–379. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Selamat SA, Chung BS, Girard L, Zhang W,
Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, et al:
Genome-scale analysis of DNA methylation in lung adenocarcinoma and
integration with mRNA expression. Genome Res. 22:1197–1211. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoo S, Takikawa S, Geraghty P, Argmann C,
Campbell J, Lin L, Huang T, Tu Z, Foronjy RF, Spira A, et al:
Integrative analysis of DNA methylation and gene expression data
identifies EPAS1 as a key regulator of COPD. PLoS Genet.
11:e10048982015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li YF, Hsiao YH, Lai YH, Chen YC, Chen YJ,
Chou JL, Chan MW, Lin YH, Tsou YA, Tsai MH and Tai CK: DNA
methylation profiles and biomarkers of oral squamous cell
carcinoma. Epigenetics. 10:229–236. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy-analysis of affymetrix genechip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pickering CR, Zhang J, Yoo SY, Bengtsson
L, Moorthy S, Neskey DM, Zhao M, Alves Ortega MV, Chang K, Drummond
J, et al: Integrative genomic characterization of oral squamous
cell carcinoma identifies frequent somatic drivers. Cancer Discov.
3:770–781. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oghumu S, Knobloch TJ, Terrazas C,
Varikuti S, Ahn-Jarvis J, Bollinger CE, Iwenofu H, Weghorst CM and
Satoskar AR: Deletion of macrophage migration inhibitory factor
inhibits murine oral carcinogenesis: Potential role for chronic
pro-inflammatory immune mediators. Int J Cancer. 139:1379–1390.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J Royal Statistical Society Series B. 57:289–300.
1995.
|
|
18
|
Merico D, Isserlin R, Stueker O, Emili A
and Bader GD: Enrichment map: A network-based method for gene-set
enrichment visualization and interpretation. PLoS One.
5:e139842010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu J, Mao X, Cai T, Luo J and Wei L: KOBAS
server: A web-based platform for automated annotation and pathway
identification. Nucleic Acids Res. 34:W720–W724. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang X, Han H, De Carvalho DD, Lay FD,
Jones PA and Liang G: Gene body methylation can alter gene
expression and is a therapeutic target in cancer. Cancer Cell.
26:577–590. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Khatami F, Larijani B, Heshmat R, Keshtkar
A, Mohammadamoli M, Teimoori-Toolabi L, Nasiri S and Tavangar SM:
Meta-analysis of promoter methylation in eight tumor-suppressor
genes and its association with the risk of thyroid cancer. PLoS
One. 12:e01848922017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jones PA: Functions of DNA methylation:
Islands, start sites, gene bodies and beyond. Nat Rev Genet.
13:484–492. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hayashido Y, Hamana T, Yoshioka Y, Kitano
H, Koizumi K and Okamoto T: Plasminogen activator/plasmin system
suppresses cell-cell adhesion of oral squamous cell carcinoma cells
via proteolysis of E-cadherin. Int J Oncol. 27:693–698.
2005.PubMed/NCBI
|
|
26
|
Kunkel M, Reichert TE, Benz P, Lehr HA,
Jeong JH, Wieand S, Bartenstein P, Wagner W and Whiteside TL:
Overexpression of Glut-1 and increased glucose metabolism in tumors
are associated with a poor prognosis in patients with oral squamous
cell carcinoma. Cancer. 97:1015–1024. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Aggarwal S, Sharma SC and Das N S:
Dynamics of regulatory T cells (Tregs) in patients with
oral squamous cell carcinoma. J Surg Oncol. 116:1103–1113. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang H, Wu Q, Liu Z, Luo X, Fan Y, Liu Y,
Zhang Y, Hua S, Fu Q, Zhao M, et al: Downregulation of FAP
suppresses cell proliferation and metastasis through PTEN/PI3K/AKT
and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death
Dis. 5:e11552014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li G, Li X, Yang M, Xu L, Deng S and Ran
L: Prediction of biomarkers of oral squamous cell carcinoma using
microarray technology. Sci Rep. 7:421052017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Boldrup L, Gu X, Coates PJ, Norberg-Spaak
L, Fahraeus R, Laurell G, Wilms T and Nylander K: Gene expression
changes in tumor free tongue tissue adjacent to tongue squamous
cell carcinoma. Oncotarget. 8:19389–19402. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zanaruddin SN, Saleh A, Yang YH, Hamid S,
Mustafa WM, Bariah Khairul AA, Zain RB, Lau SH and Cheong SC:
Four-protein signature accurately predicts lymph node metastasis
and survival in oral squamous cell carcinoma. Hum Pathol.
44:417–426. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hashimoto T, Uchida K, Okayama N, Imate Y,
Suehiro Y, Hamanaka Y, Ueyama Y, Shinozaki F, Yamashita H and
Hinoda Y: Association of matrix metalloproteinase (MMP)-1 promoter
polymorphism with head and neck squamous cell carcinoma. Cancer
Lett. 211:19–24. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yen CY, Chen CH, Chang CH, Tseng HF, Liu
SY, Chuang LY, Wen CH and Chang HW: Matrix metalloproteinases (MMP)
1 and MMP10 but not MMP12 are potential oral cancer markers.
Biomarkers. 14:244–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jayakumar A, Kang Ya, Mitsudo K, Henderson
Y, Frederick MJ, Wang M, El-Naggar AK, Marx UC, Briggs K and
Clayman GL: Expression of LEKTI domains 6–9′ in the baculovirus
expression system: Recombinant LEKTI domains 6–9′ inhibit trypsin
and subtilisin A. Protein Expr Purif. 35:93–101. 2004. View Article : Google Scholar : PubMed/NCBI
|
